Selective GH secretagogue
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al
All three doses met the primary and key secondary endpoints
24.2% after 14 hr, n=33
For example, your doctor may have you take the diabetes drug metformin with Rybelsus
This work was supported by the Major Project of the Science and Technology Innovation 2030 of China (2021ZD0202103 and 2021ZD0203500), the National Natural Science Foundation of China (82171492, 32200827, and 82271534), the Department of Science and Technology of Guangdong Province (2023B1515040009 and 2024A1515011612), and the Science, Technology and Innovation Commission of Shenzhen (RCJC20200714114556103, ZDSYS20190902093601675, and JCYJ20210324141201003)